Serial #97441927
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97441927 Trademark

Serial Number: 97441927

Serial #97441927 is a trademark filed by RECHERCHES NEURO-HIPPOCAMPE INC. NEURO-HIPPOCAMPUS RESEARCH INC. on June 3, 2022. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 18 (Leather Goods), Class 21 (Housewares), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Trademark Details

Filing Date

June 3, 2022

Registration Date

Not Registered

Goods & Services

Promotional items, namely, cups and mugs

Clinical diagnostic services, namely, performing diagnosis of medical conditions, diseases and illnesses; clinical diagnostic services, namely, performing diagnosis of predisposition for medical conditions, diseases and illnesses, characterizations of disease, response to therapy, patient selection, prognosis and reoccurrence; diagnostic, analytical, testing and monitoring services, namely, medical testing for diagnostic or treatment purposes; medical and healthcare services

Promotional items, namely, pens

Training clinical trial site personnel in the field of drug protocol requirements and the use of tests and rating systems for such protocol

Promotional items, namely, all-purpose carrying bags

Business management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; clinical trial services, namely, data processing services in the field of clinical trial data; business management assistance and consultation for clinical trials of investigational drugs

Pharmaceutical evaluation services, namely, conducting early evaluations in the field of new pharmaceuticals; clinical trial services, namely, scientific research in the nature of conducting clinical trials for others; preclinical services, namely, scientific research in the field of biological and chemical material; clinical research in the field of neuroscience; scientific research in the nature of conducting clinical trials for others in the field of biotechnology, pharmacology, and medical research; medical research in the field of the design and conducting of clinical trials; technical consulting services in the field of scientific research in the nature of clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 22, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 23, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 23, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 23, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 8, 2026 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 26, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 26, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 26, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 26, 2025 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 7, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 7, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 7, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 16, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 17, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 17, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 17, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 16, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 16, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 16, 2024 CNSL
ASSIGNED TO LIE
Sep 14, 2024 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 29, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 2, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 2, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 2, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 1, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 10, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 10, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 10, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 15, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2022 NWOS
NEW APPLICATION ENTERED
Jun 7, 2022 NWAP